Literature DB >> 34906290

SARS-CoV-2 Circulation, Guinea, March 2020-July 2021.

Solène Grayo, Cécile Troupin, Moussa Moïse Diagne, Houlou Sagno, Isabelle Ellis, Bakary Doukouré, Amadou Diallo, Jean-Mathieu Bart, Mohamed Lamine Kaba, Benoit Henry, Billy Sivahera Muyisa, Mamadou Saliou Sow, Ndongo Dia, Ousmane Faye, Sakoba Keita, Noël Tordo.   

Abstract

This overview of severe acute respiratory syndrome coronavirus 2 circulation over 1.5 years in Guinea demonstrates that virus clades and variants of interest and concern were progressively introduced, mostly by travellers through Conakry, before spreading through the country. Sequencing is key to following virus evolution and establishing efficient control strategies.

Entities:  

Keywords:  COVID-19; Guinea; SARS-CoV-2; West Africa; complete genome sequencing; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; variants; viruses; zoonoses

Mesh:

Year:  2021        PMID: 34906290      PMCID: PMC8798712          DOI: 10.3201/eid2802.212182

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In Guinea, the index coronavirus disease (COVID-19) case-patient identified on March 12, 2020, was an expatriate traveling back from Europe. Immediately, a COVID-19 task force was established by the Agence Nationale de Sécurité Sanitaire; 6 national laboratories were involved in the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. As of July 16, 2021, a total of 24,668 confirmed cases (23,571 recovered persons and 188 deaths) have been reported (https://www.anss-guinee.org). The Institut Pasteur de Guinée has contributed to the testing of >25,000 human nasopharyngeal swab samples. Most samples originated in the Conakry area from the Donka University Hospital and the Alpha Yaya Military Hospital, which serve the general population, and from the Health Center of the French Embassy, which serves mostly expatriates or travelers. We selected a panel of 252 (12.26%) SARS-CoV-2–positive samples taken during March 12, 2020–July 16, 2021, for whole-genome sequencing, which was performed at the World Health Organization Collaborative Centre of the Institut Pasteur de Dakar, to examine the evolution of SARS-CoV-2 in Guinea. From these 252 samples, 226 sequences were generated; we excluded 90 sequences showing >10% missing nucleotides. We analyzed the remaining 136 (54%) sequences by using Nextclade (https://clades.nextstrain.org) and Pangolin software (https://cov-lineages.org). The Guinea sequences are distributed into 7 clades (Appendix Figure): 20A clade (n = 55, 40.44%), 20B clade (n = 31, 22.80%), 20C clade (n = 1, 0.74%), 20D clade (n = 8, 5.88%), 20I clade (20I/B.1.1.7/Alpha; n = 19, 13.97%), 21A clade (21A/B.1.617.2/Delta; n = 16, 11.76%), and 21D clade (21D/B.1.525/Eta; n = 6, 4.41%) (Figure, panel A). The 7 clades are subdivided into subclades. None of these subclades gather sequences from specific prefectures in Guinea, suggesting that SARS-CoV-2 viruses circulating inside the country are related to Conakry cases. At the time of this writing, >21 sublineages of SARS-CoV-2 viruses were circulating in Guinea (Table).
Figure

Phylogenetic and temporal descriptions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences from Institut Pasteur de Guinée from samples collected in Guinea during March 12, 2020–July 16, 2021. A) Maximum-likelihood phylogenetic tree of 136 SARS-CoV-2 genomic sequences. The tree was constructed with IQ-tree software by using multiple-genome sequence alignment and Wuhan-Hu-1 strain (GenBank accession no. NC 045512) as outgroup reference sequence, indicated by the red asterisk. Branches and the sequence names are colored according to Nextclade assigned clades: 20A, light gray; 20B, medium gray; 20C, dark gray; 20D, black; 20I/B.1.1.7/Alpha, blue; 21A/B.1.617.2/Delta, azure; 21D/B.1.525/Eta, yellow. Each sequence is highlighted by a black tip. Scale bar indicates the distance corresponding to substitution per site. B) Chronologic distribution of SARS-CoV-2 genomic variants over 17 months in Guinea. The 136 selected sequences are assigned by Nextclade and classified according to sampling date from March 31, 2020, to July 16, 2021. Clades are colored as in panel A.

Table

Characteristics of clades and lineages identified among the Institut Pasteur de Guinée SARS-CoV-2 sequences from samples taken in Guinea during March 12, 2020–July 16, 2021*

Clade and lineage
Worldwide

Africa

Guinea†
1st described
Location
No. sequences
1st described
Location
No. sequences
1st described
No. sequences
20A
B.12020 JanUK83,6322020 MarRDC2,8162020 Mar43
B.1.36.102020 MarUnited States8242020 AprSouth Africa172021 Jan1
B.1.2102020 MarIndia403NoNo02020 Oct1
B.1.2432020 MarUnited States13,0912020 JunKenya62020 Jun1
B.1.2982020 MarUnited States397NoNo02020 Oct1
B.1.5402020 FebIndia2,1862020 MarGambia, Kenya1342020 Jun2
B.1.6222021 JanRéunion76NoNo02020 Sep1
B.1.629
2021 Jan
Belgium
84

Unknown
Guinea
14

2021 Mar
5
20B
B.1.12020 JanUK48,1192020 FebNigeria1,3612020 Mar16
B.1.1.392020 MarSwitzerland1,861NoNo02021 Jan1
B.1.1.1422020 MarAustralia51NoNo02021 Apr1
B.1.1.2362020 FebUK1,4042020 MarSouth Africa362020 Mar1
B.1.1.316.1‡2020 JanSierra Leone10,4442020 JanSierra Leone352020 Dec4
B.1.1.3172020 FebRussia2,4352020 JunZimbabwe42020 Aug1
B.1.1.3182021 JanUK3,3502021 JanNigeria3602021 Feb6
B.1.1.372
2020 Mar
UK
1,381

2020 May
South Africa
16

2020 Jul
1
20C
B.1.575
2020 Oct
United States
3,026

2020 Dec
Senegal
12

2021 Jan
1
20D
B.1.1.1
2020 Mar
UK
3,078

2020 Mar
RDC
169

2020 Sep
8
20I
B.1.1.7 (Alpha)
2020 Sep
UK
1,045,206

2020 Dec
Ghana
2,047

2021 Jan
19
21A
B.1.617.2 (Delta)
2020 Nov
India
261,339

2021 Mar
South Africa
1,662

2021 May
16
21D
B.1.525 (Eta)2020 DecUK, Nigeria7,7522020 DecNigeria5812021 Jan6

*Clades and lineages are respectively assigned according to Nextclade definition (https://github.com/nextstrain/ncov/blob/master/docs/src/reference/naming_clades.md) and PANGO lineages list (https://github.com/cov-lineages/pangolin) at the same assignment date (August 14, 2021). The Guinea sequences are distributed in 21 lineages clustered into 7 clades: 20A clade (n = 55, 40.44%) with 8 lineages (B.1, B.1.36.10, B.1.210, B.1.243, B.1.298, B.1.540, B.1.622, and B.1.629), 20B clade (n = 31, 22.80%) with 8 lineages (B.1.1, B.1.1.39, B.1.1.142, B.1.1.236, B.1.1.316.1, B.1.1.317, B.1.1.318, and B.1.1.372), 20C clade (n = 1, 0.74%) with 1 lineage (B.1.575), 20D clade (n = 8, 5.88%) with 1 lineage (B.1.1.1), 20I clade (n = 19, 13.97%) with 1 lineage (B.1.1.7 [Alpha]), 21A clade (n = 16, 11.76%) with 1 lineage (B.1.617.2 [Delta]) and 21D clade (n = 6, 4.41%) with 1 lineage (B.1.525 [Eta]). For each lineage, the first worldwide and African descriptions are provided (date and location), as well as the number of deposited sequences in GISAID (August 16, 2021). RDC, Democratic Republic of the Congo; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UK, United Kingdom. †First description and number of sequences in this study. ‡B.1.1.316.1 lineage alias R.1.

Phylogenetic and temporal descriptions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences from Institut Pasteur de Guinée from samples collected in Guinea during March 12, 2020–July 16, 2021. A) Maximum-likelihood phylogenetic tree of 136 SARS-CoV-2 genomic sequences. The tree was constructed with IQ-tree software by using multiple-genome sequence alignment and Wuhan-Hu-1 strain (GenBank accession no. NC 045512) as outgroup reference sequence, indicated by the red asterisk. Branches and the sequence names are colored according to Nextclade assigned clades: 20A, light gray; 20B, medium gray; 20C, dark gray; 20D, black; 20I/B.1.1.7/Alpha, blue; 21A/B.1.617.2/Delta, azure; 21D/B.1.525/Eta, yellow. Each sequence is highlighted by a black tip. Scale bar indicates the distance corresponding to substitution per site. B) Chronologic distribution of SARS-CoV-2 genomic variants over 17 months in Guinea. The 136 selected sequences are assigned by Nextclade and classified according to sampling date from March 31, 2020, to July 16, 2021. Clades are colored as in panel A. *Clades and lineages are respectively assigned according to Nextclade definition (https://github.com/nextstrain/ncov/blob/master/docs/src/reference/naming_clades.md) and PANGO lineages list (https://github.com/cov-lineages/pangolin) at the same assignment date (August 14, 2021). The Guinea sequences are distributed in 21 lineages clustered into 7 clades: 20A clade (n = 55, 40.44%) with 8 lineages (B.1, B.1.36.10, B.1.210, B.1.243, B.1.298, B.1.540, B.1.622, and B.1.629), 20B clade (n = 31, 22.80%) with 8 lineages (B.1.1, B.1.1.39, B.1.1.142, B.1.1.236, B.1.1.316.1, B.1.1.317, B.1.1.318, and B.1.1.372), 20C clade (n = 1, 0.74%) with 1 lineage (B.1.575), 20D clade (n = 8, 5.88%) with 1 lineage (B.1.1.1), 20I clade (n = 19, 13.97%) with 1 lineage (B.1.1.7 [Alpha]), 21A clade (n = 16, 11.76%) with 1 lineage (B.1.617.2 [Delta]) and 21D clade (n = 6, 4.41%) with 1 lineage (B.1.525 [Eta]). For each lineage, the first worldwide and African descriptions are provided (date and location), as well as the number of deposited sequences in GISAID (August 16, 2021). RDC, Democratic Republic of the Congo; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UK, United Kingdom. †First description and number of sequences in this study. ‡B.1.1.316.1 lineage alias R.1. During March–August 2020, the sequences were exclusively distributed into 2 clades, 20A and 20B, globally circulating in West and Central Africa (Table; Figure, panel B) (–). Their ancestral position in the maximum-likelihood tree outlines their introduction in Guinea, most likely from Europe as illustrated by the index case. Their circulation has persisted in a nonexclusive manner up to May–July 2021. The 20D clade, sparsely detected in Africa (Table), was observed in Guinea through >2 introductions in September and October 2020, according to the topology of the maximum-likelihood tree (Figure, panel B). Moreover, a single case of 20C clade originating from North America was detected in January 2021 in a person traveling from Haiti (Table; Figure, panel B). In 2021, new SARS-CoV-2 variants of concern (VOC) and variants of interest, reputed to be more transmissible, emerged in Guinea (). The VOC 20I/B.1.1.7/Alpha variant, which originally emerged in the United Kingdom, was first identified in Guinea in January 2021, increased in incidence up to March 2021, and then decreased from April to June 2021, corresponding to the dynamic described in Africa (Figure, panel B) (–,; E.A. Ozer et al., unpub. data, https://www.medrxiv.org/content/10.1101/2021.04.09.21255206v3). The variant of interest 21D/B.1.525/Eta was identified in Guinea and other countries in Central and West Africa in February–May 2021 (Table) (; E.A. Ozer et al., unpub. data). The topology of the Guinea maximum-likelihood tree with only one subclade of this variant suggests a unique introduction in this study. Finally, the 21A/B.1.617.2/Delta VOC was first detected in May 2021 in Guinea (Figure, panel B). By July, it had become dominant; >90% of the sequenced viruses by Institut Pasteur de Guinée demonstrated the same dynamics observed during May–August 2021 in Africa (). The maximum-likelihood tree suggests >2 main introductions of this variant in Guinea. In summary, although only 20A and 20B clades circulated in Guinea for the first 6 months of the pandemic (March–August 2020), the reopening of borders and commercial flights have progressively enabled the introduction of variants from surrounding parts of Africa (21D/B.1.525/Eta) and globally (20I/B.1.1.7/Alpha and 21A/B.1.617.2/Delta) several months after their original detection (Table). Although the 20I/B.1.1.7/Alpha and 21A/B.1.617.2/Delta variants have spread successfully in the population, the 21D/B.1.525/Eta variant has only occasionally been detected. We did not detect other variants previously found in Africa, such as the 20H/B.1.351/Beta variant (which populated 50% of sequences in Africa during January–May 2021) and variants from the sublineage A, including the A.23.1 lineage from East Africa and the A.27 lineage of uncertain origin, in this study (1–3,5; E.A. Anoh et al., unpub. data, https://www.medrxiv.org/content/10.1101/2021.05.06.21256282v1). This overview of the circulation of SARS-CoV-2 viruses in Guinea furthers the examination of infectious diseases control strategies in Africa, which faces vaccination implementation delay (). Beside classical quantitative reverse transcription PCR diagnostic testing, strengthening of the sequencing capacity is the cornerstone of tracking and fighting the emergence of SARS-CoV-2 variants in real time (). Making countries autonomous in sequencing is the next challenge in fighting COVID-19, as well as other emerging zoonoses, in Africa.

Appendix

Additional information about SARS-CoV-2 circulation, Guinea, March 2020–July 2021
  6 in total

1.  Covid-19: Africa scrambles to increase genomic testing capacity as variants spread.

Authors:  Abdullahi Tsanni
Journal:  BMJ       Date:  2021-05-07

2.  A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

Authors:  Eduan Wilkinson; Marta Giovanetti; Houriiyah Tegally; James E San; Richard Lessells; Diego Cuadros; Darren P Martin; David A Rasmussen; Abdel-Rahman N Zekri; Abdoul K Sangare; Abdoul-Salam Ouedraogo; Abdul K Sesay; Abechi Priscilla; Adedotun-Sulaiman Kemi; Adewunmi M Olubusuyi; Adeyemi O O Oluwapelumi; Adnène Hammami; Adrienne A Amuri; Ahmad Sayed; Ahmed E O Ouma; Aida Elargoubi; Nnennaya A Ajayi; Ajogbasile F Victoria; Akano Kazeem; Akpede George; Alexander J Trotter; Ali A Yahaya; Alpha K Keita; Amadou Diallo; Amadou Kone; Amal Souissi; Amel Chtourou; Ana V Gutierrez; Andrew J Page; Anika Vinze; Arash Iranzadeh; Arnold Lambisia; Arshad Ismail; Audu Rosemary; Augustina Sylverken; Ayoade Femi; Azeddine Ibrahimi; Baba Marycelin; Bamidele S Oderinde; Bankole Bolajoko; Beatrice Dhaala; Belinda L Herring; Berthe-Marie Njanpop-Lafourcade; Bronwyn Kleinhans; Bronwyn McInnis; Bryan Tegomoh; Cara Brook; Catherine B Pratt; Cathrine Scheepers; Chantal G Akoua-Koffi; Charles N Agoti; Christophe Peyrefitte; Claudia Daubenberger; Collins M Morang'a; D James Nokes; Daniel G Amoako; Daniel L Bugembe; Danny Park; David Baker; Deelan Doolabh; Deogratius Ssemwanga; Derek Tshiabuila; Diarra Bassirou; Dominic S Y Amuzu; Dominique Goedhals; Donwilliams O Omuoyo; Dorcas Maruapula; Ebenezer Foster-Nyarko; Eddy K Lusamaki; Edgar Simulundu; Edidah M Ong'era; Edith N Ngabana; Edwin Shumba; Elmostafa El Fahime; Emmanuel Lokilo; Enatha Mukantwari; Eromon Philomena; Essia Belarbi; Etienne Simon-Loriere; Etilé A Anoh; Fabian Leendertz; Faida Ajili; Fakayode O Enoch; Fares Wasfi; Fatma Abdelmoula; Fausta S Mosha; Faustinos T Takawira; Fawzi Derrar; Feriel Bouzid; Folarin Onikepe; Fowotade Adeola; Francisca M Muyembe; Frank Tanser; Fred A Dratibi; Gabriel K Mbunsu; Gaetan Thilliez; Gemma L Kay; George Githinji; Gert van Zyl; Gordon A Awandare; Grit Schubert; Gugu P Maphalala; Hafaliana C Ranaivoson; Hajar Lemriss; Happi Anise; Haruka Abe; Hela H Karray; Hellen Nansumba; Hesham A Elgahzaly; Hlanai Gumbo; Ibtihel Smeti; Ikhlas B Ayed; Ikponmwosa Odia; Ilhem Boutiba Ben Boubaker; Imed Gaaloul; Inbal Gazy; Innocent Mudau; Isaac Ssewanyana; Iyaloo Konstantinus; Jean B Lekana-Douk; Jean-Claude C Makangara; Jean-Jacques M Tamfum; Jean-Michel Heraud; Jeffrey G Shaffer; Jennifer Giandhari; Jingjing Li; Jiro Yasuda; Joana Q Mends; Jocelyn Kiconco; John M Morobe; John O Gyapong; Johnson C Okolie; John T Kayiwa; Johnathan A Edwards; Jones Gyamfi; Jouali Farah; Joweria Nakaseegu; Joyce M Ngoi; Joyce Namulondo; Julia C Andeko; Julius J Lutwama; Justin O'Grady; Katherine Siddle; Kayode T Adeyemi; Kefentse A Tumedi; Khadija M Said; Kim Hae-Young; Kwabena O Duedu; Lahcen Belyamani; Lamia Fki-Berrajah; Lavanya Singh; Leonardo de O Martins; Lynn Tyers; Magalutcheemee Ramuth; Maha Mastouri; Mahjoub Aouni; Mahmoud El Hefnawi; Maitshwarelo I Matsheka; Malebogo Kebabonye; Mamadou Diop; Manel Turki; Marietou Paye; Martin M Nyaga; Mathabo Mareka; Matoke-Muhia Damaris; Maureen W Mburu; Maximillian Mpina; Mba Nwando; Michael Owusu; Michael R Wiley; Mirabeau T Youtchou; Mitoha O Ayekaba; Mohamed Abouelhoda; Mohamed G Seadawy; Mohamed K Khalifa; Mooko Sekhele; Mouna Ouadghiri; Moussa M Diagne; Mulenga Mwenda; Mushal Allam; My V T Phan; Nabil Abid; Nadia Touil; Nadine Rujeni; Najla Kharrat; Nalia Ismael; Ndongo Dia; Nedio Mabunda; Nei-Yuan Hsiao; Nelson B Silochi; Ngoy Nsenga; Nicksy Gumede; Nicola Mulder; Nnaemeka Ndodo; Norosoa H Razanajatovo; Nosamiefan Iguosadolo; Oguzie Judith; Ojide C Kingsley; Okogbenin Sylvanus; Okokhere Peter; Oladiji Femi; Olawoye Idowu; Olumade Testimony; Omoruyi E Chukwuma; Onwe E Ogah; Chika K Onwuamah; Oshomah Cyril; Ousmane Faye; Oyewale Tomori; Pascale Ondoa; Patrice Combe; Patrick Semanda; Paul E Oluniyi; Paulo Arnaldo; Peter K Quashie; Philippe Dussart; Phillip A Bester; Placide K Mbala; Reuben Ayivor-Djanie; Richard Njouom; Richard O Phillips; Richmond Gorman; Robert A Kingsley; Rosina A A Carr; Saâd El Kabbaj; Saba Gargouri; Saber Masmoudi; Safietou Sankhe; Salako B Lawal; Samar Kassim; Sameh Trabelsi; Samar Metha; Sami Kammoun; Sanaâ Lemriss; Sara H A Agwa; Sébastien Calvignac-Spencer; Stephen F Schaffner; Seydou Doumbia; Sheila M Mandanda; Sherihane Aryeetey; Shymaa S Ahmed; Siham Elhamoumi; Soafy Andriamandimby; Sobajo Tope; Sonia Lekana-Douki; Sophie Prosolek; Soumeya Ouangraoua; Steve A Mundeke; Steven Rudder; Sumir Panji; Sureshnee Pillay; Susan Engelbrecht; Susan Nabadda; Sylvie Behillil; Sylvie L Budiaki; Sylvie van der Werf; Tapfumanei Mashe; Tarik Aanniz; Thabo Mohale; Thanh Le-Viet; Tobias Schindler; Ugochukwu J Anyaneji; Ugwu Chinedu; Upasana Ramphal; Uwanibe Jessica; Uwem George; Vagner Fonseca; Vincent Enouf; Vivianne Gorova; Wael H Roshdy; William K Ampofo; Wolfgang Preiser; Wonderful T Choga; Yaw Bediako; Yeshnee Naidoo; Yvan Butera; Zaydah R de Laurent; Amadou A Sall; Ahmed Rebai; Anne von Gottberg; Bourema Kouriba; Carolyn Williamson; Daniel J Bridges; Ihekweazu Chikwe; Jinal N Bhiman; Madisa Mine; Matthew Cotten; Sikhulile Moyo; Simani Gaseitsiwe; Ngonda Saasa; Pardis C Sabeti; Pontiano Kaleebu; Yenew K Tebeje; Sofonias K Tessema; Christian Happi; John Nkengasong; Tulio de Oliveira
Journal:  Science       Date:  2021-09-09       Impact factor: 63.714

3.  Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early 2021.

Authors:  Anna-Lena Sander; Anges Yadouleton; Edmilson F de Oliveira Filho; Carine Tchibozo; Gildas Hounkanrin; Yvette Badou; Praise Adewumi; Keke K René; Dossou Ange; Salifou Sourakatou; Eclou Sedjro; Melchior A J Aïssi; Hinson Fidelia; Mamoudou Harouna Djingarey; Michael Nagel; Wendy Karen Jo; Andres Moreira-Soto; Christian Drosten; Olfert Landt; Victor Max Corman; Benjamin Hounkpatin; Jan Felix Drexler
Journal:  Emerg Infect Dis       Date:  2021-08-31       Impact factor: 6.883

Review 4.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.